Effects of chitosan-coated pressed calcium sulfate pellets combined with recombinant human bone morphogenetic protein 2 on bone formation in femoral condyle-contained bone defects

Journal of Craniofacial Surgery

Volumn 21, Issue 1, 2010, Pages 188-197

  Chen, Hua ^a   Cui, Xu ^a   Yu, Xuezhong ^a   Tian, Xuezhong ^a   Zhang, Boxun ^a   Tang, Peifu ^a   Wang, Yan ^a  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

Bone healing; Bone morphogenetic protein; Calcium sulfate; Chitosan

Indexed keywords

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN; CALCIUM SULFATE; CHITOSAN; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; COMPRESSIVE STRENGTH; DRUG EFFECT; FEMUR; HUMAN; MALE; OSTEOLYSIS; RABBIT; RANDOMIZATION;

ANIMALS; BONE DENSITY; BONE MORPHOGENETIC PROTEINS; BONE RESORPTION; CALCIUM SULFATE; CHITOSAN; COATED MATERIALS, BIOCOMPATIBLE; COMPRESSIVE STRENGTH; FEMUR; HUMANS; MALE; OSTEOGENESIS; RABBITS; RANDOM ALLOCATION; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 77649225574     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/SCS.0b013e3181c50f8f     Document Type: Article

References (71)

1. Kelly CM, Wilkins RM, Gitelis S, et al. The use of a surgical grade calcium sulfate as a bone graft substitute: results of a multicenter trial. Clin Orthop Relat Res 2001;42-50
2. Thomas MV, Puleo DA, Al-Sabbagh M. Calcium sulfate: a review. J Long Term Eff Med Implants 2005;15:599-607
3. Thomas MV, Puleo DA. Calcium sulfate: properties and clinical applications. J Biomed Mater Res B Appl Biomater 2009;88:597-610
4. Apaydin ES, Torabinejad M. The effect of calcium sulfate on hard-tissue healing after periradicular surgery. J Endod 2004;30:17-20
5. Andreana S, Cornelini R, Edsberg LE, et al. Maxillary sinus elevation for implant placement using calcium sulfate with and without DFDBA: six cases. Implant Dent 2004;13:270-277
6. Harris RJ. Clinical evaluation of a composite bone graft with a calcium sulfate barrier. J Periodontol 2004;75:685-962
7. Conner HD. Bone grafting with a calcium sulfate barrier after root amputation. Compend Contin Educ Dent 1996;17:42, 44, 46
8. Turner TM, Urban RM, Gitelis S, et al. Radiographic and histologic assessment of calcium sulfate in experimental animal models and clinical use as a resorbable bone-graft substitute, a bone-graft expander, and a method for local antibiotic delivery. One institution's experience. J Bone Joint Surg Am 2001;83-A(suppl 2 pt 1):8-18
9. Alexander DI, Manson NA, Mitchell MJ. Efficacy of calcium sulfate plus decompression bone in lumbar and lumbosacral spinal fusion: preliminary results in 40 patients. Can J Surg 2001;44: 262-266
10. Gitelis S, Piasecki P, Turner T, et al. Use of a calcium sulfate-based bone graft substitute for benign bone lesions. Orthopedics 2001;24:162-166
11. Lind MC, Jensen TB, Laursen M, et al. Clinical use of bone graft substitutes in orthopedic surgery. Status and future possibilities. Ugeskr Laeger 2003;165:3712-3717
12. Urban RM, Turner TM, Hall DJ, et al. Effects of altered crystalline structure and increased initial compressive strength of calcium sulfate bone graft substitute pellets on new bone formation. Orthopedics 2004;27(suppl 1):s113-s118
13. Gao C, Gao J, You X, et al. Fabrication of calcium sulfate/PLLA composite for bone repair. J Biomed Mater Res A 2005;73:244-253
14. Mamidwar SS, Arena C, Kelly S, et al. In vitro characterization of a calcium sulfate/PLLA composite for use as a bone graft material. J Biomed Mater Res B Appl Biomater 2007;81:57-65
15. Gao C, Huo S, Li X, et al. Characteristics of calcium sulfate/gelatin composite biomaterials for bone repair. J Biomater Sci Polym Ed 2007;18:799-824
16. Winn SR, Hollinger JO. An osteogenic cell culture system to evaluate the cytocompatibility of Osteoset, a calcium sulfate bone void filler. Biomaterials 2000;21:2413-2425
17. Urban RM, Turner TM, Hall DJ, et al. Healing of large defects treated with calcium sulfate pellets containing demineralized bone matrix particles. Orthopedics 2003;26(suppl 5):s581-s585
18. Turner TM, Urban RM, Hall DJ, et al. Osseous healing using injectable calcium sulfate-based putty for the delivery of demineralized bone matrix and cancellous bone chips. Orthopedics 2003;26(suppl 5):s571-s575
19. Teng SH, Lee EJ, Park CS, et al. Bioactive nanocomposite coatings of collagen/hydroxyapatite on titanium substrates. J Mater Sci Mater Med 2008;19:2453-2461
20. Kawai T, Anada T, Honda Y, et al. Synthetic octacalcium phosphate augments bone regeneration correlated with its content in collagen scaffold. Tissue Eng Part A 2009;15:23-32
21. Bil M, Ryszkowska J, Roether JA, et al. Bioactivity of polyurethane-based scaffolds coated with Bioglass. Biomed Mater 2007;2:93-101
22. Miao X, Tan DM, Li J, et al. Mechanical and biological properties of hydroxyapatite/tricalcium phosphate scaffolds coated with poly(lactic-co- glycolic acid). Acta Biomater 2008;4:638-645
23. Siepmann F, Siepmann J, Walther M, et al. Polymer blends for controlled release coatings. J Control Release 2008;125:1-15
24. Schmidmaier G, Lucke M, Schwabe P, et al. Collective review: bioactive implants coated with poly(D,L-lactide) and growth factors IGF-I, TGF-beta1, or BMP-2 for stimulation of fracture healing. J Long Term Eff Med Implants 2006;16:61-69
25. Bumgardner JD, Wiser R, Gerard PD, et al. Chitosan: potential use as a bioactive coating for orthopaedic and craniofacial/dental implants. J Biomater Sci Polym Ed 2003;14:423-438
26. Sinha VR, Singla AK, Wadhawan S, et al. Chitosan microspheres as a potential carrier for drugs. Int J Pharm 2004;274:1-33
27. Prabaharan M. Review paper: chitosan derivatives as promising materials for controlled drug delivery. J Biomater Appl 2008;23:5-36
28. Suh JK, Matthew HW. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review. Biomaterials 2000;21:2589-2598
29. Di Martino A, Sittinger M,Risbud MV. Chitosan: a versatile biopolymer for orthopaedic tissue-engineering. Biomaterials 2005; 26:5983-5990
30. Ohara N, Hayashi Y, Yamada S, et al. Early gene expression analyzed by cDNA microarray and RT-PCR in osteoblasts cultured with water-soluble and low molecular chitooligosaccharide. Biomaterials 2004;25:1749-1754
31. Bumgardner JD, Wiser R, Elder SH, et al. Contact angle, protein adsorption and osteoblast precursor cell attachment to chitosan coatings bonded to titanium. J Biomater Sci Polym Ed 2003; 14:1401-1409
32. Lahiji A, Sohrabi A, Hungerford DS, et al. Chitosan supports the expression of extracellular matrix proteins in human osteoblasts and chondrocytes. J Biomed Mater Res 2000;51:586-595
33. Yeo YJ, Jeon DW, Kim CS, et al. Effects of chitosan nonwoven membrane on periodontal healing of surgically created one-wall intrabony defects in beagle dogs. J Biomed Mater Res B Appl Biomater 2005;72:86-93
34. VandeVord PJ, Matthew HW, DeSilva SP, et al. Evaluation of the biocompatibility of a chitosan scaffold in mice. J Biomed Mater Res 2002;59:585-590
35. Muzzarelli RA, Mattioli-Belmonte M, Tietz C, et al. Stimulatory effect on bone formation exerted by a modified chitosan. Biomaterials 1994;15:1075-1081
36. Urist MR. Bone: formation by autoinduction. Science 1965; 150:893-899
37. Urist MR, Strates BS. Bone morphogenetic protein. J Dent Res 1971;50:1392-1406
38. Rosen V, Wozney JM, Wang EA, et al. Purification and molecular cloning of a novel group of BMPs and localization of BMP mRNA in developing bone. Connect Tissue Res 1989;20:313-319
39. Laursen M, Hoy K, Hansen ES, et al. Recombinant bone morphogenetic protein-7 as an intracorporal bone growth stimulator in unstable thoracolumbar burst fractures in humans: preliminary results. Eur Spine J 1999;8:485-490
40. Booth KC, Bridwell KH, Eisenberg BA, et al. Minimum 5-year results of degenerative spondylolisthesis treated with decompression and instrumented posterior fusion. Spine 1999;24:1721-1727
41. Ames CP, Smith JS, Preul MC, et al. Effect of recombinant human bone morphogenetic protein-2 in an experimental model of spinal fusion in a radiated area. Spine 2005;30:2585-2592
42. Itoh H, Ebara S, Kamimura M, et al. Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2. Spine 1999;24:1402-1405
43. Boden SD, Moskovitz PA, Morone MA, et al. Video-assisted lateral intertransverse process arthrodesis. Validation of a new minimally invasive lumbar spinal fusion technique in the rabbit and nonhuman primate (rhesus) models. Spine 1996;21:2689-2697
44. Cui X, Zhang B, Wang Y, et al. Effects of chitosan-coated pressed calcium sulfate pellet combined with recombinant human bone morphogenetic protein 2 on restoration of segmental bone defect. J Craniofac Surg 2008;19:459-465
45. Code of Federal Regulations. 9 CRF, parts 1, 2, 3. Animal Rights and Animal Products. Document no. CFR 9CFR1-99.
46. Orr TE, Villars PA, Mitchell SL, et al. Compressive properties of cancellous bone defects in a rabbit model treated with particles of natural bone mineral and synthetic hydroxyapatite. Biomaterials 2001; 22:1953-1959
47. Mihelic NE. Repair of a severely comminuted distal femur fracture using surgical-grade calcium sulfate bone graft substitute. Orthopedics 2004;27(suppl 1):s127-s128
48. Borrelli J Jr, Prickett WD, Ricci WM. Treatment of nonunions and osseous defects with bone graft and calcium sulfate. Clin Orthop Relat Res 2003;411:245-254
49. Cho BC, Park JW, Baik BS, et al. Clinical application of injectable calcium sulfate on early bony consolidation in distraction osteogenesis for the treatment of craniofacial microsomia. J Craniofac Surg 2002;13:465-475
50. Mirzayan R, Panossian V, Avedian R, et al. The use of calcium sulfate in the treatment of benign bone lesions. A preliminary report. J Bone Joint Surg Am 2001;83-A:355-358
51. Strocchi R, Orsini G, Iezzi G, et al. Bone regeneration with calcium sulfate: evidence for increased angiogenesis in rabbits. J Oral Implantol 2002;28:273-278
52. Paolantonio M, Perinetti G, Dolci M, et al. Surgical treatment of periodontal intrabony defects with calcium sulfate implant and barrier versus collagen barrier or open flap debridement alone: a 12-month randomized controlled clinical trial. J Periodontol 2008;79:1886-1893
53. Silveira RL, Machado RA, Silveira CR, et al. Bone repair process in calvarial defects using bioactive glass and calcium sulfate barrier. Acta Cir Bras 2008;23:322-328
54. Kim CK, Kim HY, Chai JK, et al. Effect of a calcium sulfate implant with calcium sulfate barrier on periodontal healing in 3-wall intrabony defects in dogs. J Periodontol 1998,69:982-988
55. Pecora G, Andreana S, Margarone JE 3rd, et al. Bone regeneration with a calcium sulfate barrier. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:424-429
56. Sidqui M, Collin P, Vitte C, et al. Osteoblast adherence and resorption activity of isolated osteoclasts on calcium sulphate hemihydrate. Biomaterials 1995;16:1327-1332
57. Mamidwar S, Weiner M, Alexander H, et al. In vivo bone response to calcium sulfate/poly L-lactic acid composite. ImplantDent 2008;17:208-216
58. Amano K, Ito E. The action of lysozyme on partially deacetylated chitin. Eur J Biochem 1978;85:97-104
59. Pangburn SH, Trescony PV, Heller J. Lysozyme degradation of partially deacetylated chitin, its films and hydrogels. Biomaterials 1982;3:105-108
60. Shigemasa Y, Saito K, Sashiwa H, et al. Enzymatic degradation of chitins and partially deacetylated chitins. Int J Biol Macromol 1994;16:43-49
61. Jull AB, Ni Mhurchu C, Bennett DA, et al. Chitosan for overweight or obesity. Cochrane Database Syst Rev 2008;CD003892
62. Kojima K, Okamoto Y, Kojima K, et al. Effects of chitin and chitosan on collagen synthesis in wound healing. J Vet Med Sci 2004;66: 1595-1598
63. Ueno H, Ohya T, Ito H, et al. Chitosan application to x-ray irradiated wound in dogs. J Plast Reconstr Aesthet Surg 2007;60:304-310
64. Yang J, Tian F, Wang Z, et al. Effect of chitosan molecular weight and deacetylation degree on hemostasis. J Biomed Mater Res B Appl Biomater 2008;84:131-137
65. Gustafson SB, Fulkerson P, Bildfell R, et al. Chitosan dressing provides hemostasis in swine femoral arterial injury model. Prehosp Emerg Care 2007;11:172-178
66. Park SS, Kim SG, Lim SC, et al. Osteogenic activity of the mixture of chitosan and particulate dentin. J Biomed Mater Res A 2008; 87:618-623
67. Lian Q, Li DC, He JK, et al. Mechanical properties and in-vivo performance of calcium phosphate cementYchitosan fibre composite. Proc Inst Mech Eng [H] 2008;222:347-353
68. Kawai T, Yamada T, Yasukawa A, et al. Biological fixation of fibrous materials to bone using chitin/chitosan as a bone formation accelerator. J Biomed Mater Res B Appl Biomater 2009;88:264-270
69. Bumgardner JD, Chesnutt BM, Yuan Y, et al. The integration of chitosan-coated titanium in bone: an in vivo study in rabbits. Implant Dent 2007;16:66-79
70. Park DJ, Choi BH, Zhu SJ, et al. Injectable bone using chitosan-alginate gel/mesenchymal stem cells/BMP-2 composites. J Craniomaxillofac Surg 2005;33:50-54
71. Cho BC, Kim TG, Yang JD, et al. Effect of calcium sulfate-chitosan composite: pellet on bone formation in bone defect. J Craniofac Surg 2005;16:213-224